GB202014969D0 - ZIP12 antibody - Google Patents

ZIP12 antibody

Info

Publication number: GB202014969D0
Authority: GB; United Kingdom
Prior art keywords: zip12; antibody; zip12 antibody
Prior art date: 2020-09-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB2014969.6A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Appollo Therapeutics

Original Assignee

Appollo Therapeutics

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2020-09-22

Filing date

2020-09-22

Publication date

2020-11-04

2020-09-22 Application filed by Appollo Therapeutics filed Critical Appollo Therapeutics

2020-09-22 Priority to GBGB2014969.6A priority Critical patent/GB202014969D0/en

2020-11-04 Publication of GB202014969D0 publication Critical patent/GB202014969D0/en

Status Ceased legal-status Critical Current

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
GBGB2014969.6A GB202014969D0 (en)	2020-09-22	2020-09-22	ZIP12 antibody

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB2014969.6A GB202014969D0 (en)	2020-09-22	2020-09-22	ZIP12 antibody

Publications (1)

Publication Number	Publication Date
GB202014969D0 true GB202014969D0 (en)	2020-11-04

Family

ID=73196794

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB2014969.6A Ceased GB202014969D0 (en)	2020-09-22	2020-09-22	ZIP12 antibody

Country Status (1)

Country	Link
GB (1)	GB202014969D0 (en)

2020
- 2020-09-22 GB GBGB2014969.6A patent/GB202014969D0/en not_active Ceased

Similar Documents

Publication	Publication Date	Title
PL3872091T3 (en)	2023-12-27	Antibodies against sars-cov-2
IL308741A (en)	2024-01-01	Anti-sirp-alpha antibodies
RS66234B1 (en)	2024-12-31	Anti-ccr8 antibodies
GB202105110D0 (en)	2021-05-26	Anti-CD73 antibodies
ZA202108836B (en)	2023-04-26	Anti-epha4 antibody
GB202111905D0 (en)	2021-10-06	Antibodies
IL300142A (en)	2023-03-01	ANTI-IL13Ralpha2 ANTIBODIES
GB202014851D0 (en)	2020-11-04	SARS-COV-2 antibodies
IL299767A (en)	2023-03-01	Anti-αlpha-4-βeta-7 antibodies
SG11201913540VA (en)	2020-10-29	Anti-Podoplanin Antibody
GB202309981D0 (en)	2023-08-16	Antibody
IL308782A (en)	2024-01-01	Antibodies
IL308100A (en)	2023-12-01	Antibodies
GB202015115D0 (en)	2020-11-11	ZIP12 Antibody
GB201919062D0 (en)	2020-02-05	Antibody
GB202106027D0 (en)	2021-06-09	Antibody
GB202105933D0 (en)	2021-06-09	Anti-IL1rap antibody
GB202014969D0 (en)	2020-11-04	ZIP12 antibody
GB202208773D0 (en)	2022-07-27	Anti-SARS2-S antibodies
IL307175A (en)	2023-11-01	Il-38-specific antibodies
GB202116709D0 (en)	2022-01-05	Antibodies
GB202115824D0 (en)	2021-12-15	Antibodies
GB202112297D0 (en)	2021-10-13	Antibodies
GB202107517D0 (en)	2021-07-07	Antibodies
GB202104128D0 (en)	2021-05-05	Antibodies

Legal Events

Date	Code	Title	Description
2020-10-21	AT	Applications terminated before publication under section 16(1)